Elisa Tiberi
Ancona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 14, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 23, 2025
Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.
Journal: The oncologist
Published: June 13, 2025
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer.
Journal: Therapeutic advances in medical oncology
Published: April 24, 2025
Adjuvant treatment with Capecitabine in patients who received orthotopic liver transplantation with incidental diagnosis of intrahepatic cholangiocarcinoma. Implications on DPYD polymorphisms assessment: report of two cases and review of the literature.
Journal: Cancer chemotherapy and pharmacology
Published: November 12, 2024
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.
Journal: Breast (Edinburgh, Scotland)
Published: October 22, 2024
Immunotherapy in Triple-Negative Breast Cancer.
Journal: Oncology and therapy
Published: July 08, 2024
Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer.
Journal: Cancers
Published: October 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026